This site is currently under going scheduled maintenance.
Please check back soon.
Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women11
An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind11, 12
Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)13
The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body 2, 11, 14
Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy15